Health
Biological E. Limited gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate – United News of India
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed…
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC).BE started the Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate in the second week of November…
-
General17 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General20 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News19 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business17 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher